Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

Finasteride use may increase the risk of male breast cancer.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Pranic meditation significantly improved mental health and quality of life for breast cancer survivors.

The new patient-controlled expansion technique for breast reconstruction is safe, efficient, and cost-effective.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Semecarpus anacardium leaf extract fights breast cancer and extends survival in mice.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The document explains how to create detailed biological pathways using genomic data and tools, with examples of hair and breast development.

Electromagnetic energy from wound dressing paste can disrupt skin lipid droplets, possibly affecting cancer development.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

The document explains breast development, common breast conditions, and their treatments.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.